Tandem Diabetes Care (NASDAQ:TNDM) had its price target raised by analysts at Stifel Nicolaus from $16.00 to $20.00. They now have a "hold" rating on the stock.
1 Small-Cap Stock with Exciting Potential and 2 Facing Headwinds [Yahoo! Finance]
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Is Tandem Diabetes Care (TNDM) Starting To Look Attractive After Prolonged Share Price Weakness? [Yahoo! Finance]
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM